About Affect Therapeutics
Affect Therapeutics is a private company based in McLean, Virginia, incorporated in 2020 in Delaware. It has reported $24,577,640 raised in two offerings on Form D since September 2021. Its chief executive is Kristin Muhlner.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 16, 2022 | Jul 12, 2023 | $18,073,362fully sold | 9 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Jun 23, 2021 | Sep 23, 2021 | $6,504,278fully sold | 10 | $650K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $24,577,640 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Affect Therapeutics's Form D filed Jul 12, 2023.
JR
Jeff Rinehart
Director
KR
Kevin Ryan
Director
JD
Jeff DeFlavio
Director
SP
Stuart Peterson
Director
KM
Kristin Muhlner
Chief Executive Officer and director